Global Apheresis Equipment Market; Strategic Business

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
231
Global Apheresis Equipment Market; Strategic Business Report 2016-2024: Increase in Number of Platelet Donors Drives Apheresis Procedures

Dublin, July 05, 2018 (GLOBE NEWSWIRE) -- The "Apheresis Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets in US$ thousand by the following Type of Apheresis Equipment:

  • Equipment for Therapeutic Apheresis
  • Equipment for Donor Apheresis

The global market is additionally analyzed by the following Procedures:

  • Photopheresis
  • Plasmapheresis
  • Others

The report profiles 14 companies including many key and niche players such as:

  • Asahi Kasei Medical Co., Ltd. (Japan)
  • B Braun Melsungen AG (Germany)
  • Cerus Corporation (USA)
  • Fresenius Kabi (Germany)
  • Haemonetics Corporation (USA)
  • Kaneka Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Mallinckrodt Pharmaceuticals (Ireland)
  • Medica SpA (Italy)
  • NIKKISO Europe GmbH (Germany)
  • Terumo BCT, Inc. (USA)

Key Topics Covered

1. INDUSTRY OVERVIEW Apheresis Equipment Rising Adoption of Therapeutic and Donor Apheresis Favors Growth Donor Apheresis & Therapeutic Apheresis Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth Plasmapheresis Systems Dominate Apheresis Equipment Market Neurology The Major Application Area for Apheresis Equipment Developed Markets Continue to Lead Apheresis Equipment Market Developing Nations to Lead the Charge in Future Rising Demand for Plasma from Biopharmaceutical Companies Opportunity to Tap Sustained Growth in Blood Collections Favors Apheresis Equipment Market Competitive Landscape Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers 2. KEY MARKET TRENDS & DRIVERS Rising Cancer Incidence to Drive Volume of Apheresis Procedures Technological Advancements and Novel Indications Augur Well for Apheresis Market Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market Photopheresis: A Popular Therapeutic Apheresis Procedure Plasmapheresis Continues to Lead the Apheresis Market Plateletpheresis Emerges as the Treatment of Choice' Increase in Number of Platelet Donors Drives Apheresis Procedures Pediatrics: An Unexplored Domain in Therapeutic Apheresis Automated Blood Processing Systems in Open Heart Surgeries CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease Improving Healthcare Expenditure to Drive Demand Aging Population: A Strong Growth Driver Key Challenges & Issues Lack of Awareness among Patients Restrains Market Growth Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis Development of Inexpensive Apheresis Therapies Shortage of Qualified Donors Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment 3. TECHNOLOGY OVERVIEW 4. BLOOD COMPONENTS & DERIVATIVES Red Blood Cells (RBCs) White Blood Cells (WBCs) Platelets Sources of Blood Plasma Facts About Plasma and its Donation Pre-requisites for Plasma Donors Ionic Composition of Blood Types of Blood General Facts about Blood General Uses of Blood Blood Global Facts 5. PRODUCT INNOVATIONS/INTRODUCTIONS Fresenius Introduces 6008 CAREsystem Terumo BCT Launches Correct Connect System FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia USFDA Clears PMN Protocol for Terumo's Spectra Optia 6. RECENT INDUSTRY ACTIVITY Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System Terumo BCT Receives CE Mark for Spectra Optia Apheresis System Terumo BCT Enters into Distribution Agreement with B Medical Systems Mallinckrodt Takes Over Therakos HemaCare Sells Therapeutic Apheresis Assets to Fresenius Terumo BCT Files FDA Submission to Improve Blood Supply Safety Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study Terumo opens Production Facility in Vietnam Terumo Collaborates with Kaneka Terumo to Distribute Therakos Products in Latin America Terumo Enters Distribution Agreement with Therakos 7. FOCUS ON SELECT PLAYERS Asahi Kasei Medical Co., Ltd. (Japan) B Braun Melsungen AG (Germany) Cerus Corporation (USA) Fresenius Kabi (Germany) Haemonetics Corporation (USA) Kaneka Corporation (Japan) Kawasumi Laboratories, Inc. (Japan) Mallinckrodt Pharmaceuticals (Ireland) Medica SpA (Italy) NIKKISO Europe GmbH (Germany) Terumo BCT, Inc. (USA) 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 14 (including Divisions/Subsidiaries 20)

  • The United States (8)
  • Japan (3)
  • Europe (9)
    • Germany (5)
    • Italy (3)
    • Rest of Europe (1)

For more information about this report visit https://www.researchandmarkets.com/research/p...resis?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Medical Devices, Blood Banking

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles

Top 5 Most Recently Viewed Articles

Exploring the Rise of the Aluminum Alloy Wheel Market

Updated Category News Views 91

Overview of the Aluminum Alloy Wheel Market The Aluminum Alloy Wheel market has experienced notable growth and shows a bright future ahead. With ongoing innovations from manufacturers and shifting consumer preferences, the market is projected to reach approximately USD 33.2 billion by 2033. This growth translates to an estimated compound annual growth rate (CAGR) of 7.2%...

Continue Reading
Prominent Speakers Set to Illuminate Fortune Global Forum

Updated Category News Views 191

Global Icons to Speak at Fortune Global Forum 2024 Excitement is building around the upcoming Fortune Global Forum, where some of the most influential leaders in business and policy will converge. This event, set for November 11-12, promises rich dialogues on pressing global issues. Among the key figures attending are Tom Brady, the renowned seven-time world champion, and...

Continue Reading
IGT Unveils Diverse Wheel of Fortune Products at G2E 2024

Updated Category News Views 187

IGT Launches Exciting New Offerings for Wheel of Fortune International Game Technology PLC, better known as IGT, is famous for creating vibrant and engaging gaming experiences. At the upcoming Global Gaming Expo (G2E), IGT will proudly showcase a range of new products dedicated to the beloved Wheel of Fortune brand. Attendees can look forward to an exciting lineup that...

Continue Reading
Market Dynamics and Short Selling Insights About Disney

Updated Category News Views 132

Understanding Short Selling for Walt Disney Walt Disney's short percent of float has experienced a notable increase, now standing at 8.04% from the latest report. Presently, there are 21.70 million shares sold short, which accounts for 1.21% of all available regular shares. With the current trading volume, it is estimated that it would take around 3.12 days on average for...

Continue Reading
Heritage Commerce Corp Announces Quarterly Dividend of $0.13

Updated Category News Views 155

Heritage Commerce Corp Declares Dividend to Shareholders Heritage Commerce Corp (NASDAQ: HTBK), a respected bank holding company in the financial sector, recently shared exciting news with its stakeholders. The Board of Directors has approved a cash dividend of $0.13 per share for all common stock holders. This positive announcement reflects the company's commitment to...

Continue Reading